MoonLake Immunotherapeutics
NASDAQ:MLTX
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
38.43
63.86
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
MLTX Price Targets Summary
MoonLake Immunotherapeutics
According to Wall Street analysts, the average 1-year price target for MLTX is 75.4 USD with a low forecast of 55.55 USD and a high forecast of 109.2 USD.
MLTX Last Price Targets
MoonLake Immunotherapeutics
The latest public price target was made on Jul 1, 2024 by Raghuram Selvaraju from H.C. Wainwright , who expects MLTX stock to rise by 83% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Raghuram Selvaraju
H.C. Wainwright
|
100
USD
Upside 83% |
4 months ago
Jul 1, 2024
|
H.C. Wainwright Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
StreetInsider
|
Richard Law
Goldman Sachs
|
62
USD
Upside 14% |
7 months ago
Apr 2, 2024
|
Goldman Sachs Starts Moonlake Immunotherapeutics (MLTX ) at Neutral, 'Competing Against Large Pharma Companies Is No Easy Task'
StreetInsider
|
Serge Belanger
Needham
|
76
USD
Upside 39% |
1 year ago
Aug 31, 2023
|
Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts
Benzinga
|
|
Raghuram Selvaraju
H.C. Wainwright
|
28
USD
Downside 49% |
2 years ago
Jul 22, 2022
|
MoonLake Immunotherapeutics (MLTX) Stock: Why It Increased 4.63% Today
Pulse 2.0
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MLTX's stock price target?
Price Target
75.4
USD
According to Wall Street analysts, the average 1-year price target for MLTX is 75.4 USD with a low forecast of 55.55 USD and a high forecast of 109.2 USD.
You don't have any saved screeners yet
